Nucleosides

3-Cyanovinylcarbazole phosphoramidite is a novel compound that has not been previously described. It is a deoxyribonucleoside monophosphate and can be used as an anticancer agent. 3-Cyanovinylcarbazole phosphoramidite is also an antiviral, which can inhibit the synthesis of viral DNA. The modified nucleosides in this compound are synthesized by modifying the ribonucleotide with a cyanovinyl group at the C-3 position, which can be used as phosphoramidites for DNA synthesis.

8-azido-2-deoxyadenosine is an azide funcationalised nuceleoside

5'-O-Trityluridine is a nucleoside analogue that has been prepared as an oriented, oxidized, hydrogenated, xylene derivative of uridine. It is composed of ribofuranoside and uridine. The orientation is controlled by the use of trityl groups on the 5' and 3' hydroxyl groups. The alkali metal salt isomers are analysed using HPLC and GC. This compound interacts with phosphotriesters and cyclic phosphodiesters.

Clevudine is a synthetic pyrimidine analogue effective against the hepatitis B virus (HBV). Once inside the cell, it is converted into its active forms, clevudine monophosphate and clevudine triphosphate. The triphosphate form competes with thymidine to be incorporated into viral DNA, leading to DNA chain termination and inhibition of the HBV DNA polymerase (reverse transcriptase). Due to its long half-life, clevudine significantly reduces covalently closed circular DNA (cccDNA), making relapse less likely after treatment ends.

An azanucleoside and epigenetic modulator that interferes with nucleic acid metabolism. The compound gets incorporated into RNA and inhibits ribonucleotide reductase subunit RRM2 in leukemia cell lines. Intracellularly, 5-azacytidine can get converted into 2′-deoxy-5-azacytidine (decitabine) and subsequently incorporated in DNA, where it irreversibly inhibits DNMT1 methyltransferase. In human epithelial cell lines, this compound decreases Src-activated expression of a histone chaperone CAF1 and inhibits cell motility and invasiveness.

Furano-dt cep is a novel antiviral drug that has been shown to inhibit the production of viral nucleic acid and to activate the immune system. Furano-dt cep is a phosphoramidite compound that is synthesized from ribonucleosides and deoxyribonucleosides, which are modified with 2,2-dithiobis(propionitrile). Furano-dt cep binds to the 5'-terminal phosphate group on the DNA strand, preventing RNA synthesis. Furano-dt cep also inhibits tumor growth by causing cell death through apoptosis.

3’-Azido-3’-deoxy-2-thiouridine is an antiviral agent that is used to synthesize phosphoramidites for the preparation of modified oligonucleotides. 3’-Azido-3’-deoxy-2-thiouridine has been shown to inhibit cancer growth and induce apoptosis in cancer cells, suggesting that it may have anticancer properties. It is also a novel deoxyribonucleoside that can be used as a building block for the synthesis of ribonucleosides. 3’-Azido-3’-deoxy-2-thiouridine is a high quality product with high purity and excellent activator properties. This product has CAS No. 2305416–00–4 and can be used in pharmaceuticals, biotechnology, and other chemical applications.

9-(3'-O-methyl-β-D-xylofuranosyl)adenine is a synthetic nucleoside that is an activator of viral DNA polymerase. 9-(3'-O-methyl-β-D-xylofuranosyl)adenine is a novel nucleoside that has been shown to be active against both DNA and RNA viruses. This compound also has anticancer activity. 9-(3'-O-methyl-β-D-xylofuranosyl)adenine is the phosphorylated form of adenine and has high purity and quality. The CAS number for this product is 53110-86-2.

Pro-drug of 5-FU; anti-cancer agent

Fmoc-morpholino adenosine monomer is a synthetic nucleoside that is used in the synthesis of oligonucleotides for use as antiviral and anticancer agents. Fmoc-morpholino adenosine monomer has been synthesized by modifying the deoxyribonucleosides, which are then phosphoramidite derivatives of ribonucleosides. This novel chemical compound has shown high activity against DNA-dependent RNA polymerase, suggesting that it may be an effective antiviral agent.

5-(Carboxymethyl)uridine is an uridine compound that has been shown to inhibit protein synthesis in cultured cells. It binds to the ribosome and inhibits protein synthesis by inhibiting the formation of peptide bonds. 5-Carboxymethyl-uridine has been shown to be effective against two strains of bacteria, Escherichia coli and Staphylococcus aureus, in cell culture experiments. The inhibition of bacterial protein synthesis was shown to be dose-dependent for both strains. The mechanism of action is believed to be due to its binding to the ribosome and inhibiting the formation of peptide bonds.

Inhibitor of uridine monophosphate synthase

6-Thioinosine 5'-monophosphate (6TIMP) is a hydrogen bond donor that possesses inhibitory properties against protein synthesis. It has been shown to have an anti-inflammatory effect and can be used for the treatment of inflammatory bowel disease. 6TIMP is also able to inhibit the bcr-abl kinase, which is implicated in the development of renal cell cancer. 6TIMP can be administered intravenously or orally and penetrates tissues well. The rate at which it enters cells is dependent on the transport rate, which is determined by its acidity. 6TIMP has been shown to cause DNA damage, leading to apoptosis and cell death in carcinoma cell lines. The mechanism of action appears to involve inhibition of cellular protein synthesis, acid formation, and DNA damage.

2'-Deoxy-5-iodocytidine is a modified monophosphate of deoxyribonucleosides. It is used as an activator in the synthesis of phosphoramidites and nucleosides, as well as in antiviral and anticancer drug development. This product has been shown to have high purity and quality. 2'-Deoxy-5-iodocytidine has also been shown to be active against HIV, hepatitis B, herpes simplex virus type 1, and cytomegalovirus.

1-(2'-Deoxy-5'-O-DMT-b-D-xylofuranosyl) cytosine is a modified nucleoside that is phosphoramidite activated by the addition of a diphosphate. The diphosphate group on the sugar moiety may be hydrolyzed to form 1-(2'-deoxy-5'-O-DMT-b-D-xylofuranosyl)cytosine monophosphate. Cytidine is an antiviral and antifungal agent that is used in the treatment of herpes zoster, chronic myeloid leukemia, and other cancers. It has been shown to inhibit DNA synthesis and viral replication in vitro.
!--More-->
Cytidine is an antiviral and antifungal agent that is used in the treatment of herpes zoster, chronic myeloid leukemia, and other cancers. It has been shown to inhibit DNA

1-(3'-Deoxy-3'-fluoro-b-D-xylofuranosyl)cytosine is a novel nucleoside that has been synthesized and characterized as a phosphoramidite monophosphate. It is a high purity, synthetic, DNA nucleoside that has shown antiviral and anticancer activities in vitro. 1-(3'-Deoxy-3'-fluoro-b-D-xylofuranosyl)cytosine is an activator of DNA polymerase δ and can be used as a modified nucleotide in nucleic acid synthesis. This compound has the CAS number 4384802-52-5.

5’-Deoxy-5’-iodo-2’-O-methyl-5-methyluridine is a monophosphate nucleoside. It is an antiviral and anticancer agent that inhibits viral replication by inhibiting the synthesis of viral DNA. It also has been shown to have antitumor activity, but it can only be used in cancer treatments when combined with other drugs such as 5FU. The chemical formula for 5’-Deoxy-5’-iodo-2’O methyl -5 methyl uridine is C10H14N4O8P.